- Report
- August 2024
- 82 Pages
Japan
From €3104EUR$3,500USD£2,704GBP
- Report
- October 2024
- 200 Pages
Global
From €4389EUR$4,949USD£3,823GBP
- Report
- April 2023
- 122 Pages
Global
From €4212EUR$4,750USD£3,670GBP
- Report
- April 2025
- 61 Pages
China
From €1596EUR$1,800USD£1,391GBP
- Report
- April 2025
- 227 Pages
China
From €3547EUR$4,000USD£3,090GBP
- Report
- April 2025
- 114 Pages
China
From €1596EUR$1,800USD£1,391GBP
- Report
- February 2025
- 120 Pages
Global
From €4301EUR$4,850USD£3,747GBP
- Report
- June 2023
- 84 Pages
Global
From €3500EUR$4,228USD£3,156GBP
- Report
- October 2023
- 109 Pages
Global
From €3500EUR$4,228USD£3,156GBP
- Report
- November 2025
- 132 Pages
Global
From €842EUR$950USD£734GBP
The Sleep Disorder Drug market is a subset of the Central Nervous System Drugs market. It includes drugs used to treat a variety of sleep disorders, such as insomnia, narcolepsy, and sleep apnea. These drugs are typically classified as hypnotics, sedatives, or anxiolytics, and can be prescribed in the form of tablets, capsules, or liquids. Commonly prescribed sleep disorder drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
The Sleep Disorder Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Sanofi, Merck, GlaxoSmithKline, Novartis, and Takeda. Other companies include Sunovion, Jazz Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more